Biotalys Past Earnings Performance

Past criteria checks 0/6

Biotalys's earnings have been declining at an average annual rate of -15.5%, while the Chemicals industry saw earnings growing at 6.9% annually.

Key information

-15.5%

Earnings growth rate

86.1%

EPS growth rate

Chemicals Industry Growth23.2%
Revenue growth raten/a
Return on equity-83.4%
Net Marginn/a
Next Earnings Update19 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Biotalys makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTBR:BTLS Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-16613
31 Mar 240-18715
31 Dec 230-21717
30 Sep 230-22718
30 Jun 230-24720
31 Mar 230-23719
31 Dec 220-23719
30 Sep 220-21617
30 Jun 220-20615
31 Mar 220-18615
31 Dec 210-17614
30 Sep 210-15513
30 Jun 210-13512
31 Mar 210-12412
31 Dec 200-11311
31 Dec 196-1020
31 Dec 183-520
31 Dec 172-310
31 Dec 160-310
31 Dec 150-210
31 Dec 140-210

Quality Earnings: BTLS is currently unprofitable.

Growing Profit Margin: BTLS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BTLS is unprofitable, and losses have increased over the past 5 years at a rate of 15.5% per year.

Accelerating Growth: Unable to compare BTLS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BTLS is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.7%).


Return on Equity

High ROE: BTLS has a negative Return on Equity (-83.44%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 07:00
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biotalys NV is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sebastian BrayBerenberg
Guy SipsKBC Securities NV
Thomas VrankenKBC Securities NV